NeuroMind BioPharma

Pioneering research, novel molecule discovery & development

Setting the standards through collaborative development, applied research and superlative in-house experience in extraction and characterization of natural products for use in neurological disorders and rare diseases.

Our Company

Neuromind Biopharma is a biotech company drawing on the extensive experience of its directors, advisory board members and networks of expertise in research and development in the bio–pharmaceutics space. Our entry into the psychedelic arena is backed by its long history of developing therapeutics of natural origin and taking the lead from nature. We wish to further the science of harnessing the extensive source of tryptaminergic compounds from nature’s pantry.

Advancements in the biosciences increasingly demonstrate the need for diversity and versatility in bio-drug development that draws on our understanding of co-evolved metabolic pathways. There is no better example than the meta-tryptophan biome, co-evolved and differentiated across all species and kingdoms as a source of biologics for new therapeutics that impact on multiple metabolic regulatory cycles. Our scientific innovation is truly led and informed by our further understanding of the intricacies of metabolomics between all lifeforms.

Key Functions

Clinical Development

Contributing to the treatment of rare neurological disorders.

Expand the Biotech and clinical applications of naturally extracted tryptamine compounds

Biotech

Develop universal standards to be used by the industry for regulatory purposes

Extraction

Characterization and stabilization of extracts from natural origin.

Commercial production of stabilized compounds.

We are setting a pharmaceutical standard for natural product extracion which will be made available to regulators.